1. Introduction {#sec1}
===============

The control of gastro-intestinal nematodes of veterinary importance is mainly based on the use of broad spectrum anthelmintics such as levamisole, benzimidazoles and avermectins. Multiple resistant isolates could therefore represent a major threat for animal health as well as for production sustainability. For example, the haematophagous parasite *Haemonchus contortus* (barber pole worm), that is one of the most prevalent and pathogenic trichostrongylid species affecting small ruminants worldwide, has developed multiresistance against these three main classes of anthelmintics, thus stressing the need for the development of novel resistance-breaking drugs ([@bib50]; [@bib37]; [@bib26]; [@bib40]). In this respect, nicotine-sensitive acetylcholine receptors of parasitic nematodes appear to be pharmacological targets of prime interest. Acetylcholine is a major excitatory neurotransmitter in both vertebrates and invertebrates. Acetylcholine receptors are members of the cys-loop ligand-gated ion channel superfamily and consist of five subunits arranged around a central pore ([@bib49]). Each subunit possesses an N-terminal extracellular domain containing a dicysteine loop followed by four transmembrane regions (TM1--TM4) of which TM2 lines the ion channel. In nematodes, the muscular acetylcholine receptors fall into two pharmacological classes that are preferentially activated by the cholinergic agonist levamisole (L-type) or nicotine (N-type) respectively. These cholinergic agonists induce a prolonged activation of muscular AChR causing spastic paralysis of the worms, which are either killed as with the free-living nematode *Caenorhabditis elegans* or expelled from the host organism in the case of *H. contortus*. ([@bib2]; [@bib4]; [@bib23]).

The molecular composition of L-AChR and N-AChR was first deciphered in the model nematode *Caenorhabditis elegans.* The main *C. elegans* L-AChR is a heteromeric receptor composed of five subunits encoded by the *unc-38*, *unc-63*, *lev-8*, *unc-29* and *lev-1* genes respectively ([@bib30], [@bib31]; [@bib20]; [@bib15]; [@bib48]). Co-expression of these five distinct L-AChR subunits together with three additional *C. elegans* ancillary proteins led to the robust expression of a functional *C. elegans* L-AChR in *Xenopus laevis* oocytes ([@bib10]). The recombinant *C. elegans* L-AChR was found to be sensitive to levamisole (Lev) but insensitive to nicotine (Nic). The *C. elegans* N-AChR is a homomeric receptor composed of five identical subunits encoded by the *acr-16* gene and requires only the RIC-3 ancillary protein to enhance its functional expression in *Xenopus* oocytes ([@bib5]; [@bib22]). In contrast with the L-AChR subtype, the recombinant *C. elegans* N-AChR was found to be very responsive to Nic whereas Lev did not induce any response. Similarly, the recombinant N-AChR made of the ACR-16 subunits from the pig parasitic nematode *Ascaris suum* presented the same differential response between Lev and Nic as observed for its *C. elegans* counterpart ([@bib1]).

Whereas the L-AChRs are targets for several anti-parasitic drugs (for review [@bib52]) there is currently no anthelmintic on the market targeting the N-AChRs. However, several decades ago, nicotine has been used as an anthelminthic in livestock ([@bib51]; [@bib34]), therefore validating nicotine-sensitive AChR from nematode as potent anthelmintic targets.

In the present study, using an automated larval migration assay (ALMA), we provide evidence that nicotine and nicotine derivatives targeting AChR are able to paralyze a multiple drug-resistant isolate of *H. contortus*. In addition, using recombinant N-AChRs expressed in *Xenopus* oocytes, we deciphered their mode of action. Our results suggest that compounds targeting the N-AChR are potentially able to control levamisole, pyrantel and ivermectin-resistant parasites and need to be further explored.

2. Material and methods {#sec2}
=======================

2.1. Ethics statement {#sec2.1}
---------------------

All animal care and experimental procedures were conducted in strict accordance with the European guidelines for the care and use of laboratory animals and were approved by the ethical committee from Indre et Loire under experimental agreement 6623 provided by the French Veterinary Services.

2.2. Nematodes {#sec2.2}
--------------

*Haemonchus contortus* L3 larvae from the Weybridge and Kokstad isolates were obtained as previously described ([@bib17]). In the present study, the anthelmintic susceptible Weybridge isolate (UK) was used as a reference ([@bib43]). Kokstad is a field isolate from South Africa, which is resistant to benzimidazoles, ivermectin and levamisole ([@bib38]; [@bib16]; [@bib35]). However, for Kokstad isolate, pyrantel resistance status remained to be determined. In that respect, for the present study, sheep were infected with 10 000 Kokstad L3 larvae and were subsequently treated with a full dose of Levamisole (7.5 mg/kg of bodyweight) at 14 days post infection (dpi) and a full dose of pyrantel (20 mg/kg of bodyweight) at 19 dpi and finally with a full dose of ivermectin (0,2 mg/kg of bodyweight) at 24 dpi. Host faeces were collected 35 days post infection and positive fecal egg counting after treatments confirmed the Lev/Pyr/Ivm multi-resistant status of the Kokstad isolate. L3 larvae corresponding to the multiple resistant adult\'s progeny were harvested from coprocultures and used for automated larval migration assays. Benzimidazole susceptibility or resistance status of the Weybridge and Kokstad isolate was investigated by performing egg hatch assays as described by [@bib13] using thiabendazole (TBZ). The test performed in triplicate confirmed the Weybridge isolate TBZ-susceptibility (ED~50~: 0.024 ± 0.001 μg/ml) and the Kokstad isolate TBZ-resistance (ED~50~: 0.437 ± 0.205 μg/ml).

Adult *Parascaris equorum* were obtained as described in [@bib14]. *Caenorhabditis elegans* experiments were carried out on the Bristol N2; *acr-16 (ok789)* and *lev-8(ok1519)* strains obtained from the *Caenorhabditis* Genetics Center (CGC).

2.3. Automated larval migration assay {#sec2.3}
-------------------------------------

The automated larval migration assay (ALMA) used for the present study was adapted from the technology previously designed for *H. contortus* L2 motility monitoring ([@bib9]) with minor modifications. Using a Quanta Master spectrofluorometer (Horiba PTI, NJ, USA), larval motility was estimated by measuring *H. contortus* L3 auto-fluorescence resulting from ultraviolet excitation. . Motility assays were performed using 7500 *H. contortus* L3 larvae. Worms were transferred into a 5 mL glass tube and left for 15 min to concentrate by gravity. The supernatant was removed and replaced by 2 ml of tap water or anthelmintic solution. After 20 min, the tube was inverted on a 20 μm sieve. After a stabilization time of 60 s, the fluorescence accumulation (correlated to the number of larvae migrating through the sieve) was measured during 5 min . Each set of experiment was performed in triplicate.

2.4. cDNA synthesis {#sec2.4}
-------------------

Total RNA was prepared from the distinct nematode species using 50 μL of pelleted L3 larvae of *H. contortus* or 50 adults *C. elegans* or cross-section (5 mm thick) from the mid body region of an individual adult worm of *P. equorum*. Frozen samples were ground in liquid nitrogen and homogenized in Trizol reagent (Invitrogen, Carlsbad, CA, USA) and total RNA was isolated according to the manufacturer\'s recommendations. RNA pellets were dissolved in 25 μL of RNA secure resuspension solution (Ambion, Austin, TX, USA) and DNase-treated using the TURBO DNA-free kit (Ambion). RNA concentrations were measured using a nanodrop spectrophotometer (Thermo Scientific, Waltham, MA, USA). First-strand cDNA synthesis was performed on 1 μg of total RNA using the superscript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) according to the manufacturer\'s recommendations.

2.5. Cloning of complete coding cDNA sequences of *acr-16* from *H. contortus* and *P. equorum* {#sec2.5}
-----------------------------------------------------------------------------------------------

To identify the cDNA sequences from *acr-16* homologs in *H. contortus* and *P. equorum*, nested polymerase chain reactions (PCR) were performed on respective first-strand cDNA templates with the Phusion High fidelity Polymerase (New England Biolabs) and PCR products were cloned into the transcription vector pTB207 ([@bib10]) using the In-Fusion^®^HD cloning kit (Clontech). For *H. contortus*, the following primers were designed based on the *Hco-acr-*16 mRNA sequence available in Genbank (accession number [EU051823](ncbi-n:EU051823){#intref0010}): Hc-ACR16-F-Xho1 (ATGTGGAGCTTGCTGATCGC) and Hc-ACR16-R-Apa1 (CTAGGCGACCAGATATGGAG). For *P. equorum*, a blast search ([@bib3]) with Asu-ACR-16 as a query against the partial *P. equorum* genomic sequence database (available at <https://www.sanger.ac.uk/resources/downloads/helminths/>) retrieved contig NODE_2631440_length_27442_2.804278 as the best hit containing an incomplete sequence for the *acr-16* gene. Then, specific primers were designed to amplify the coding sequence of *Peq-acr-16* (FuPeq16ptbamF TCGTGTAATTGACGCTGCGTCT, FuPeq16ptbapaR CTATGCTATCGTGTAAGGCGCA, Peq-acr-16-F0 TTCAGAGTGATAACGCATAACGG, Peq-acr-16-Z1R GCAAATACGTTAGTGTAAGTATGG). The novel complete coding sequences of *acr-16* were named *Hco-acr-16* for *H. contortus* and *Peq-acr-16* for *P. equorum* according to Beech et al. recommendations ([@bib6]) and were deposited to GenBank under the accession numbers MH806893 and MH806894, respectively.

2.6. Sequence analysis {#sec2.6}
----------------------

Deduced amino-acid sequences were aligned using MUSCLE ([@bib18]). Signal peptide predictions were carried out using the SignalP 3.0 server ([@bib8]) and membrane-spanning regions were predicted using the SMART server ([@bib46]). Phylogenetic analysis was performed on deduced amino-acid sequence. Sequence from the signal peptide, the intracellular loop (between TM3 and TM4) and C-terminal tail were removed as they could not be aligned unambiguously. Maximal likelihood phylogeny reconstruction was performed using PhyML V20120412 (<https://github.com/stephaneguindon/phyml-downloads/releases>) and significance of internal tree branches was estimated using bootstrap resampling of the dataset 100 times. The accession numbers sequences used for the analysis are:

***Caenorhabditis elegans*:** ACR-5 NP_498437; ACR-6 NP_491354; ACR-7 NP_495647; ACR-8 NP_509745; ACR-9 NP_510285; ACR-10 NP_508692; ACR-11 NP_491906; ACR-12 NP_510262; ACR-13 (=LEV-8) NP_509932; ACR-14 NP_495716; ACR-15 NP_505206; ACR-16 NP_505207; ACR-17 NP_001023961; ACR-18 NP_506868; ACR-19 NP_001129756; ACR-20 NP_001122627; ACR-23 NP_504024; ACR-24 NP_001255866; DEG-3 NP_505897; DES-2 NP_001256320; EAT-2 NP_496959; LEV-1 NP_001255705;; UNC-29 NP_492399; UNC-38 NP_491472; UNC-63 NP_491533. ***Haemonchus contortus*:** Hco-ACR-16 MH806893; ***Parascaris equorum*:** Peq-ACR-16 MH806894.

### 2.6.1. *Caenorhabditis elegans* experiments {#sec2.6.1}

Worms were maintained at 20 °C on nematode growth medium (NGM) plates and fed on a bacterial lawn (*Escherichia coli* OP50). Paralysis assays were performed on gravid adults as previously described ([@bib21]).

2.7. Electrophysiology experiments {#sec2.7}
----------------------------------

The pTB207 containing either the *C. elegans, H. contortus and P. equorum acr-16* cDNAs were linearized with the *Nhe*I restriction enzyme (Thermofisher) and used as templates for cRNA synthesis using the T7 mMessage mMachine kit (Ambion). In parallel, cRNAs for the ancillary proteins Hco-RIC-3, Hco-UNC-50 and Hco-UNC-74 were also synthesized and mixed with the respective *acr-*16 cRNAs. *Xenopus laevis* defolliculated oocytes were obtained from Ecocyte Bioscience (Germany). The oocytes were injected in the animal pole with a total volume of 36 nL of cRNA mix containing 50 ng/μL of each cRNA in RNase-free water using the Drummond nanoject II microinjector. Microinjected oocytes were incubated at 20 °C for 48H before recording. Two-electrode voltage-clamp recordings were carried out using an Oocyte Clamp OC-725C amplifier (Warner instrument) on oocytes being voltage-clamped at −60 mV. The electrophysiology experiments were performed on BAPTA-free oocytes as the previous study investigating the ACR-16 N-AChR from *Ascaris suum* showed a calcium permeability (P~Ca~/P~Na~) of 0.4, indicating that the calcium ion is not the major ion going through the ACR-16 channel ([@bib1]). In accordance, we found no statistical differences in the EC~50~ values for ACh- and Nic-elicited currents resulting from BAPTA-AM-free and BAPTA-AM-treated oocytes, thus downplaying a putative confounding effect of calcium-activated chloride channels on whole-cell current responses. Acetylcholine and nicotine were dissolved in recording buffer (100 mM NaCl, 2.5 mM KCl, 1 mM CaCl~2~.2H2O, 5 mM HEPES, pH 7.3). Nornicotine and anabasine were prepared first in DMSO and diluted subsequently in recording buffer so that DMSO final concentration was less than 0.1%. Currents were recorded and analyzed using the pCLAMP 10.4 package (Molecular Devices). EC~50~ values were determined using non-linear regression on normalized data (1 mM ACh as maximal response) using GraphPad Prism^®^ software.

3. Materials {#sec3}
============

Acetylcholine chloride (ACh), ivermectin; (−)-tetramisole hydrochloride (levamisole), (−)-nicotine hydrogen tartrate, pyrantel citrate, **(±)**-nornicotine, anabasine were purchased from Sigma-Aldrich.

4. Results {#sec4}
==========

4.1. Automated larval migration assay (ALMA) confirms the multidrug resistant status of the *H. contortus* Kokstad isolate {#sec4.1}
--------------------------------------------------------------------------------------------------------------------------

We recently reported the development of the ALMA technology (Automated Larval Migration Assay), a spectrofluorometric-based approach to quantify the migration rate of the *H. contortus* L2 larvae ([@bib9]). Here, we adapted the ALMA to the L3 stage in order to use it for testing the *in vitro* anthelmintic activity of several drug standards. Interestingly, as previously reported for L2 larvae, we found a highly significant relationship between the fluorescence measured and the accumulation of L3 larvae that migrated into the recording chamber (R^2^ = 0.9977) after 5 min ([S1 Fig.](#appsec1){ref-type="sec"}). Therefore, we were able to measure the L3 migration and the *in vitro* effect of anthelmintics by quantifying the increase in fluorescence against time in the absence or presence of drug.

In order to determine their respective Lev, Pyr and Ivm susceptibility, ALMA assays were performed on *H. contortus* L3 from the anthelmintic-susceptible Weybridge (Wey) and the Lev/Pyr/Ivm multi-resistant Kokstad (Kok) isolates ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}; [S2 Fig.](#appsec1){ref-type="sec"}). In the absence of drug application, a similar pattern of migration kinetic was observed between both isolates. In contrast, dose-response assays performed with Lev, Pyr and Ivm revealed a drastic reduction of drugs efficacy on the Kok L3 in comparison with Wey worms ([Fig. 1](#fig1){ref-type="fig"}; [Fig. 3](#fig3){ref-type="fig"}; [S2 Fig.](#appsec1){ref-type="sec"}). The IC~50~ values of Lev, Pyr and Ivm were 1.14 ± 0.03 μM, 0.77 ± 0.01 μM and 6.6 ± 0.2 nM for Wey *versus* 14.01 ± 0.35 μM, 18.5 ± 1.32 μM and 100 ± 2.6 nM for Kok, respectively. Based on the respective IC~50~ values, the calculated resistance factors ([@bib27]) between Kok and Wey were 12.3, 23.9 and 15.1 confirming the Lev, Pyr and Ivm resistance status of the Kok isolate and the drug susceptibility of the Wey isolate as previously determined *in vivo* (see Material and methods section).Fig. 1**Motility modulation of H. contortus L3 larvae exposed to levamisole, pyrantel or ivermectin**. The automated larval migration assay (ALMA) was used to determine dose-dependent paralysis effect of Lev, Pyr or Ivm on the *H. contortus* L3 from Weybridge (A; C and E) or Kokstad isolate (B; D and F). Representative recording traces of the real-time fluorescence counting relative to the L3 migration during 5 min exposed to Lev (A and B); Pyr (C and D) or Ivm (E and F). Each trace corresponds to the mean data from 3 runs performed with 7500 L3 larvae. The controls correspond to untreated L3 larvae.Fig. 1Fig. 2**Motility modulation of H. contortus L3 larvae exposed to nicotine, nornicotine or anabasine**. The automated larval migration assay (ALMA) was used to determine dose-dependent paralysis effect of Nic, Nor or Ana on the *H. contortus* L3 from Weybridge (A; C and E) or Kokstad isolate (B; D and F). Representative recording traces of the real-time fluorescence counting relative to the L3 migration during 5 min exposed to Nic (A and B); Nor (C and D) or Ana (E and F). Each trace corresponds to the mean data from 3 runs performed with 7500 L3 larvae. The controls correspond to untreated L3 larvae.Fig. 2Fig. 3**Determination of the dose response relationships for levamisole (A); pyrantel (B); ivermectin (C); nicotine (D); nornicotine (E) and anabasine (F) on *H. contortus* L3 larvae using the automated larval migration assay (ALMA)**. Results are shown as the mean ± se from 3 distinct ALMA assays performed with 7500 *H. contortus* L3 larvae from the Weybridge isolate (in black) or Kokstad isolate (in red). IC~50~ values are indicated on the graphs. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 3

4.2. Nicotine and nicotinic derivatives paralyze both lev-susceptible and lev-resistant isolates {#sec4.2}
------------------------------------------------------------------------------------------------

The ALMA assay was then used to compare the effect of a set of nicotinic compounds including, nicotine (Nic), nornicotine (Nor) and anabasine (Ana) on *H. contortus* L3 from the Wey and Kok isolates ([Fig. 2](#fig2){ref-type="fig"}; [Fig. 3](#fig3){ref-type="fig"}; [S2 Fig.](#appsec1){ref-type="sec"}). The application of Nic, Nor and Ana led to migration reductions of both Wey and Kok L3. Surprisingly, whereas Kok and Wey L3 presented a similar response to Nor (IC~50~ Wey Nor (774.6 ± 36.4 μM), IC~50~ Kok Nor (791.1 ± 76.8 μM)); Kok worms were less susceptible to Nic (IC~50~ Wey Nic (611 ± 55.1 μM), IC~50~ Kok Nic (1165.6 ± 67.7 μM)) but more responsive to Ana than their Wey counterparts (IC~50~ Wey Ana (179.1 ± 7.9 μM), IC~50~ Kok Ana (141 ± 6.9 μM)). These results confirmed the anthelmintic activity of the three drugs and provided a first evidence that nicotinic compounds are efficient on the Lev/Pyr/Ivm resistant worms.

4.3. N-AChRs are relevant drug targets for the control of levamisole and pyrantel resistant worms {#sec4.3}
-------------------------------------------------------------------------------------------------

In order to get first insights about the mode of action of nicotine and nicotinic-derivatives on Lev/Pyr resistant worms, we used the free living nematode *Caenorhabditis elegans* as a model. In addition to the wild type strain Bristol N2, two *C. elegans* mutant strains lacking respectively the L-AChR or N-AChR subtype (i.e. *lev-8(oK1519)*, or *acr-16(oK789)* respectively) were used in the presents study. Note that *lev-8* null mutants were chosen among other L-AChR subunit invalidated mutant, as these worms are not impaired in their locomotion and are Lev and Pyr-resistant, thus mirroring the phenotype of *H. contortus* Kokstad L3 larvae ([@bib24]; [@bib9]).

Paralysis assays were performed as described by [@bib21] on agar plate containing 31 mM Nic, Nor or Ana ([Fig. 4](#fig4){ref-type="fig"}). Whereas N2 worms and *lev-8* mutant motilities were affected by Nic, Nor and Ana, the *acr-16* mutant lacking the N-AChR subtype was significantly less sensitive to the drugs. Taken together, these results support the hypothesis that the nematode N-AChR subtype including the ACR-16 subunit contributes to the anthelmintic effect of Nic, Nor and Ana.Fig. 4**Effects of nicotine, nornicotine or anabasine on the motility of C. *elegans***. Paralysis assays were performed on N2, acr-16 (ok789) and lev-8 (ok1519) *C. elegans* strains in agar plate containing 31 mM of nicotine (A), nornicotine (B) or anabasine (C) after 15, 30, 45 and 60 min drug exposure. Paralysis was scored based on the absence of worm\'s movement in response to prodding. Data are the mean ± SEM of n = 12, \*\*\*\*p \< 0.0001, \*\*\*p \< 0.001, \*\*p \< 0.01 and \*p \< 0.05, one way ANOVA with Bonferroni post-hoc test between N2 and the mutant strains.Fig. 4

4.4. Nicotinic derivatives activate recombinant homomeric N-AChRs expressed in *Xenopus* oocytes {#sec4.4}
------------------------------------------------------------------------------------------------

It has been previously reported that the ACR-16 AChR subunit from *C. elegans* and the distantly related pig parasite *Ascaris suum* are able to form homomeric functional N-AChRs when expressed in *Xenopus* oocytes with the RIC-3 ancillary protein ([@bib10]; [@bib1]).

In order to further investigate the mode of action of nicotinic derivatives on nematode N-AChR, full-length cDNA sequences corresponding to *acr-16* were obtained from *C. elegans*, *H. contortus* and the horse parasite *Parascaris equorum.* An alignment of the ACR-16 subunit sequences from the three nematode species is presented in [Fig. 5](#fig5){ref-type="fig"}*.* All sequences shared features of an AChR subunit including a predicted signal peptide, a "cys-loop", four transmembrane domains and the vicinal dicysteines characteristics of alpha subunits. Protein sequences were highly conserved between the Clade V and Clade III species with identities for the mature proteins, excluding the signal peptide sequence, ranging from 76% to 89%. The orthologous relationship between the *C. elegans* ACR-16 subunit with its counterparts from parasitic species was confirmed by a phylogenetic analysis ([S3 Fig.](#appsec1){ref-type="sec"}). *Hco-acr-16* and *Peq-acr-16* sequences have been deposited in Genbank with accession numbers MH806893 and MH806894 respectively.Fig. 5**Amino-acid alignments of ACR-16 subunit sequences from *Caenorhabditis elegans, Haemonchus contortus* and *Parascaris equorum***. acr-16 deduced amino-acid sequences were aligned using the MUSCLE algorithm ([@bib18]) and further processed using GeneDoc. Predicted signal peptide sequences are shaded in grey. Amino acids conserved between all the ACR-16 sequences are highlighted in dark blue. Amino acids specifically shared by ACR-16 homologs from parasitic species are highlighted in red. Amino acids specifically shared by Clade V nematode species (*C. elegans* and *H. contortus*) are highlighted in light blue. The cys-loop, the four transmembrane regions (TM1--TM4) and the primary agonist binding (YxCC) are indicated above the sequences. Cel (*Caenorhabditis elegans*), Hco (*Haemonchus contortus*), Peq (Parascaris equorum). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 5

The cRNAs encoding ACR-16 from *C. elegans, H. contortus* or *P. equorum* were micro-injected in combination with cRNAs encoding the *C. elegans* RIC-3 ancillary protein in *Xenopus* oocytes. Two days after injection, we recorded robust currents in the μA range following the perfusion of 100 μM acetylcholine (ACh) in oocytes expressing ACR-16 from *C. elegans* and *P. equorum* demonstrating that the subunits assembled into functional AChRs. As previously reported for *C. elegans* and *A. suum* ([@bib10]; [@bib1]*),* the *P. equorum* receptor made of ACR-16 displayed rapid and large activating inward currents with fast-desensitization kinetics which is a hallmark of the N-AChRs ([Fig. 6](#fig6){ref-type="fig"}). Nevertheless, Hco-ACR-16 failed to produce a functional receptor (n = 30), ([S4 Fig.](#appsec1){ref-type="sec"}). Note that neither extending the expression time nor replacing RIC-3 from *C. elegans* by the RIC-3.1 and RIC-3.2 from *H. contortus* in the cRNA mix led to a functional N-AChR made of Hco-ACR-16 subunit (n = 16).Fig. 6**Concentration-response relationships of acetylcholine and nicotine derivatives on the *P. equorum* N-AChR expressed in *Xenopus* oocytes**. Representative current traces for single oocytes perfused with acetylcholine (ACh), nicotine (Nic), anabasine (Ana) and nornicotine (Nor). The concentration of agonist (μM) is indicated above each trace.Fig. 6

Next, we obtained the ACh concentration-response curve for Cel and Peq-N-AChR with maximal current amplitude elicited by 1 mM ACh ([Fig. 7](#fig7){ref-type="fig"}). The EC~50~ value of ACh was 6.4 ± 1.1 μM (n = 6) for Peq-N-AChR ([Table 1](#tbl1){ref-type="table"}) which was markedly more sensitive to ACh than the Cel-N-AChR (21.4 ± 1.1 μM) as well as the *P. equorum* morantel heteromeric receptor (34.9 ± 1.1 μM) made of the ACR-26 and ACR-27 subunits ([@bib14]). The pharmacological profiles of Cel-N-AChR and Peq-N-AChR were then established with Nic, Nor and Ana ([Figs. 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}). As expected, both receptors were highly responsive to 100 μM Nic with 79.5 ± 7.5% of ACh response (n = 16) for Cel-N-AChR and 96.6 ± 9.2% of ACh response (n = 8) for Peq-N-AChR. In addition, the perfusion of 100 μM Nor and Ana resulted in very similar currents as for Nic ([Fig. 4](#fig4){ref-type="fig"}). Interestingly, Nic and Ana were more potent than ACh in activating the *P. equorum* N-AChR as revealed by their respective EC~50~ values (2.9 ± 0.5 μM and 1.7 ± 0.1 μM, respectively), unlike Nor (34.9 ± 7.2 μM). The *C. elegans* N-AChR was more sensitive to Nic than ACh (15.1 ± 1.3 μM *versus* 22.0 ± 1.2 μM, respectively), showed a similar EC~50~ for Ana (27.5 ± 0.9 μM) and was less responsive to Nor (67.7 ± 6.6 μM). The Hill coefficient for the two N-AChRs ranged from 1.7 ± 0.2 (Nic, n = 8) to 2.7 ± 0.4 (Nor, n = 7) suggesting that more than one molecule must occupy the receptor to open the channel ([Table 1](#tbl1){ref-type="table"}). As a control, the nicotinic derivatives were also applied to the levamisole-sensitive receptors of *C. elegans* ([@bib10]) and *H. contortus* ([@bib11]). When perfused, Nic, Nor and Ana failed to induce significant response on oocytes expressing Cel-L-AChR and Hco-L-AChR-1 ([S5 Fig.](#appsec1){ref-type="sec"}). Similarly, Nor and Ana did elicit very small currents on few oocytes while Hco-L-AChR-2 responded robustly to Nic ([S5 Fig.](#appsec1){ref-type="sec"}). Altogether these results highlight some striking differences in the respective pharmacological properties of the *C. elegans* and *P. equorum* recombinant N-AChRs.Fig. 7**Concentration-response curves of acetylcholine and nicotine derivatives on the *C. elegans* (A) and P. equorum (B) N-AChRs expressed in *Xenopus oocytes***. The N-AChRs were challenged with acetylcholine (ACh), nicotine (Nic), anabasine (Ana) and nornicotine (Nor). All responses are normalized to 1 mM Ach. Results are shown as the mean ± se.Fig. 7Table 1Summary of the EC~50~ and Hill coefficient values for acetylcholine and nicotine derivatives on the *C. elegans* and *P. equorum* N-AChRs expressed in *Xenopus* oocytes. Results are shown as the mean ± sd. The number of eggs recorded is indicated (n).Table 1Cel N-AChRPeq N-AChRAcetylcholineEC50 (μM)22.0 ± 1.26.4 ± 0.6Hill slope2.1 ± 0.42.0 ± 0.2n126NicotineEC50 (μM)15.1 ± 1.32.9 ± 0.5Hill slope2.2 ± 0.21.7 ± 0.2n118NornicotineEC50 (μM)67.7 ± 6.634.9 ± 7.2Hill slope2.7 ± 0.41.9 ± 0.3n79AnabasineEC50 (μM)27.5 ± 0.91.7 ± 0.1Hill slope2.4 ± 0.41.8 ± 0.2n146

5. Discussion {#sec5}
=============

In the present work, using the ALMA assay we first confirmed the multiresistance status of the *H. contortus* Kokstad isolate and demonstrate that nicotine and some nicotinic derivatives can efficiently paralyze the Lev/Pyr/Ivm-resistant worms. The ALMA technology has been originally designed to quantify subtle motility modification of *H. contortus* L2 larvae associated with gene silencing ([@bib9]). Here we show that ALMA is also suitable to monitor *H. contortus* L3 motility allowing the determination of IC~50~ values for cholinergic agonists but also macrocyclic lactones. This result open the way for the systematic determination of resistance status in other *H. contortus* isolates and lays the basis for a novel drug screening approach for the identification of resistance breaking drugs.

Because different cholinergic agonists are selective for different nematode AChR subtypes, the cholinergic receptor diversity could be potentially exploited for the development of novel anthelminthic able to control resistant parasites ([@bib32]; [@bib7]; [@bib52]). In strongylid nematodes, Lev resistance has been shown to be associated with changes in binding characteristics or in the number of L-AChRs expressed in muscle cells ([@bib44], [@bib45]). In accordance with these observations, molecular investigations performed on Lev-resistant isolates from *H. contortus* identified truncated isoforms of two L-AChR subunits (i.e. ACR-8 and or UNC-63) associated with resistance ([@bib39]; [@bib19]). In the pig parasitic nematode *Oesophogostomum dentatum* resistance to Lev has been characterized as the loss of a Lev receptor while nicotine-sensitive receptors were unaffected ([@bib42]). In accordance with this result, electrophysiological studies performed in *C. elegans* showed that genetic ablation of L-AChR resulting in Lev/Pyr resistance did not impact the functionality of ACR-16-containing receptors. In addition, in the present work, we showed that *C. elegans lev-8* null mutants are sensitive to nicotine, nornicotine and anabasine, whereas these worms are resistant to both Lev and Pyr ([@bib9]). Taken together these results support the hypothesis that drugs targeting the nicotinic receptors including the ACR-16 subunit might be efficient at controlling Lev/Pyr-resistant parasites.

In *C. elegans*, the anthelminthic activity of nicotine at the neuro-muscular junction is mainly mediated by the N-AChR which is, a homomeric receptor subtype made of the ACR-16 subunit ([@bib41]; [@bib47]). In accordance, in the present work we report that the nicotinic derivatives such as Nor or Ana induce a paralysis on wild-type and *Lev-8* null mutant worms whereas *acr-16* null mutants are resistant to these drugs highlighting the N-AChR as a major contributor of nicotinic derivative sensitivity in *C. elegans*. In addition, these results further support the use of drug targeting the N-AChR as a way to control Lev/Pyr-resistant nematodes. Interestingly, in parasitic species such as *H. contortus* and *O. dentatum*, a recombinant L-AChR subtype made of UNC-63, UNC-38 and UNC-29 (i.e. Hco-L-AChR-2 and Ode 29-38-63 respectively) subunits was found to be responsive to Nic ([@bib11]; [@bib12]). Here we reported that in contrast with Nic, Hco-L-AChR-2 is readily insensitive to both Nor and Ana. Even though the contribution of Hco-L-AChR-2 to Nic sensitivity *in vivo* remains to be elucidated, it is tempting to speculate that the reduced sensitivity to Nic observed in Kok (in comparison with Wey) could be associated with a putative impairment of this Hco-L-AChR-2 subtype. Nonetheless, such a reduced sensitivity to nicotine had no impact on Nor and Ana response of Kok L3 supporting the hypothesis that a putative N-AChR subtype including the ACR-16 subunit might be a preferential target for nicotine and nicotinic derivative in *H. contortus*.

In *C. elegans*, electrophysiological studies and expression in *Xenopus* oocytes strongly suggested that the ACR-16 subunit can associate to form a homopentameric channel both *in vivo* and *in vitro* ([@bib5]; [@bib47]). In the distantly related pig parasite *A. suum*, the ACR-16 subunit was also able to form a functional homopentameric channel when co-expressed in *Xenopus* oocytes with the RIC-3 ancillary protein. These results suggested that homomeric recombinant N-AChR made of ACR-16 should be obtained for other parasitic species such as *H. contortus* and the horse parasite *P. equorum* for which Pyr resistance is an increasing concern ([@bib25]; [@bib33]; [@bib28]). In accordance with this assumption, in the present study we report that the co-expression of the ACR-16 subunit from *P. equorum* with the RIC-3 from *C. elegans* led to the robust expression of a functional AChR. In comparison with the prototypical *C. elegans* N-AChR, the *P. equorum* N-AChR was found to be more responsive to Nic, Nor and Ana. Such differences could lay the basis for directed mutagenesis experiments in both *C. elegans* and *P. equorum* respective ACR-16 subunit that will provide critical information about the binding site of their respective homomeric N-AChR.

Interestingly, if Ana has been identified as the most potent agonist on the recombinant Peq-N-AChR, this nicotine alkaloid was also the most efficient on *H. contortus* Wey and Kok L3 as revealed during ALMA assays. However, because of its potential toxicity for the host ([@bib29]), Ana is unlikely to be used as resistance breaking drugs for livestock. In that respect, the pharmacomodulation of Ana could represent an attractive approach to improve its efficacy as a potential anthelminthic. Recently, Zheng et al. ([@bib53]) showed that (S)-5-ethynyl-anabasine has higher agonist potency than other nicotine alkaloids on the recombinant *A. suum* N-AChR. If such studies open the way for the discovery of novel compounds targeting the N-AChR, there is now an urgent need to evaluate their efficacy on the parasites and also evaluate their potential toxicity for the host.

In contrast with *P. equorum*, into our hands the ACR-16 subunit from *H. contortus* failed to form a functional channel when co-expressed with RIC-3 from *C. elegans* but also using the RIC-3.1 and/or RIC-3.2 from *H. contortus* (data not shown). Here, we hypothesize that additional subunits or ancillary proteins are required to obtain a functional recombinant *H. contortus* N-AChR in *Xenopus* oocytes. Clearly, additional investigations are now required to further investigate ACR-16 containing receptors in *H. contortus*. In that respect recent progress concerning the efficient silencing of AChR subunit genes in *H. contortus* using RNAi will provide a valuable approach to decipher its role in nicotinic compound sensitivity *in vivo* ([@bib9]).

In conclusion, we provide a proof of concept that drug targeting the nematode N-AChR can efficiently control Lev/Pyr-resistant parasites.

Research effort should now focus on the identification of a wider range of N-AChR from parasitic species laying the basis for the identification of novel compounds targeting these attractive targets.
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The following are the Supplementary data to this article:Data ProfileData ProfileS1Fig. tif***H. contortus* L3 larvae migration assay using auto-fluorescence quantification**. Correlation between the fluorescence counting (counts/sec) and the number of L3 larvae that migrated to the recording chamber during 5min. Migration assays were performed using 1000, 2000, 3500, 5000 and 7500 L3 larvae respectively. Each data point represents mean ± SE of three independent runsS1Fig. tifS2Fig. tif**Comparison of the motility reduction of *H. contortus* L3 from the Weybridge vs Kokstad isolates exposed to Levamisole (Lev), Pyrantel (Pyr), Ivermectin (Ivm), Nicotine (Nic), Nornicotine (Nor), Anabasine (Ana) as determined by ALMA assays**. Mean data of the twenty last fluorescence measures ± SEM. Welsh two sample *t*-test, Wey vs Kok. \*\*\*\*p \< 0.001, \*\*\*p \< 0.001, \*\*p \< 0.01S2Fig. tifS3Fig. tif**1. Maximum likelihood tree showing relationships of ACR-16 acetylcholine receptor (AChR) subunits from *C.elegans*, *H. contortus* and *P. equorum* with other *C. elegans* AChR subunits**. Tree was built upon an alignment of AChR subunit sequences excluding the predicted signal peptide and the variable region between TM3 and TM4. The tree was rooted with DEG-3 group subunit sequences. Scale bar represents the number of substitution per site. Boostrap values \> 80% are indicated on branches. Accession numbers for sequences used in the phylogenetic analysis are provided in Material and Methods section. *C. elegans* AChR subunit groups are named as proposed by Mongan et al. ([@bib36]). Cel, Hco and Peq refer to *Caenorhabitis elegans*, *Haemonchus contortus* and *Parascaris equorum respectively*S3Fig. tifS4Fig. tif**Tentative expression of Hco-ACR-16 subunit in *Xenopus* oocytes**. Representative recording traces from a single oocyte challenged with 1 mM ACh and 1 mM Nic. Experiment repeated in three independent batches of oocytes.S4Fig. tifS5Fig. tifRepresentative recording traces showing the effect of 100 μM acetylcholine (ACh), nicotine (Nic), anabasine (Ana) and nornicotine (Nor) on *Xenopus* oocytes expressing the *C. elegans* L-AChR (A), the *H. contortus* L-AChR-1 (B) and the the *H. contortus* L-AChR-2 (C)S5Fig. tif
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